U. Cirkel

No ORCID on file · 23 papers in corpus · active 1986-2007

Study types

  • article 17
  • book-chapter 5
  • review 1

Condition tags

  • endometriosis 14
  • mesh:D004715 13
  • mesh:D017699 2
  • mesh:D004716 1
  • die_deep_infiltrating 1
  • dysmenorrhea 1
  • mesh:D004412 1
  • mesh:D004414 1
  • infertility 1
article 2007
Die Bedeutung des Adhäsionsmoleküls sICAM-1 und der Cytokine Intereleukin 1-B und TNF-α in der Pathogenese der Endometriose
·doi:10.1055/s-2007-989145

Fragestellung: Endometriose ist gekennzeichnet durch das Vorkommen von heterotop angesiedeltem endometrialem Gewebe, wobei die Ätiologie bislang noch weit gehend ungeklärt ist. Ziel der vorliegenden Untersuchungen ist es, Zusammenhänge zwis…

article 2001
Acute exacerbation of chronic maxillary sinusitis during therapy with nafarelin nasal spray
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/s0301-2115(01)00409-2
article 1998
[Ambulatory versus inpatient laparoscopy: decision aids for choice of management].
Zentralblatt fur Gynakologie

319 Patients are retrospectively competed, which underwent an inpatient or outpatient gynecological laparoscopy in 1992. Equality exists for martial status, education degree, nationality, anesthesiological risk and social structure. Outpati…

review 1996
Medical treatment of symptomatic endometriosis
Human Reproduction ·doi:10.1093/humrep/11.suppl_3.89

The concept of endometriosis and strategies for its treatment are reviewed. Treatment is mainly endocrine-based, using progestogens, danazol and luteinizing hormone-releasing hormone (LHRH) agonists. Such treatment is complex, and therapy s…

article 1995
A randomized, comparative trial of triptorelin depot (D-Trp6-LHRH) and danazol in the treatment of endometriosis
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/0028-2243(94)02016-8
article 1994
Behandlung von Endometriose mit dem GnRH-Agonisten Buserelin (Suprecur®): Eine multizentrische Studie
Geburtshilfe und Frauenheilkunde ·doi:10.1055/s-2007-1022341

A phase III multicentre study was carried out with the GnRH agonist buserelin (Suprecur) at five university institutions (Dept. of Obstetrics and Gynaecology of Essen, Kiel, Tübingen, Münster and Erlangen) to evaluate the effect of Busereli…

article 1993
Inflammatory reaction in endometriotic tissue: an immunohistochemical study
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/0028-2243(93)90052-e
book-chapter 1993
Topographie von Endometrioseherden in Abhängigkeit vom Schweregrad der Erkrankung
·doi:10.1007/978-3-642-77857-5_216
article 1993
Topographie von Endometrioseherden in Abhängigkeit vom Schweregrad der Erkrankung
·doi:10.1007/bf02266108
article 1991
Aussagekraft der Tumormarker CA 125, CA 19-9, CA 15-3 und CEA bei Endometriose
Geburtshilfe und Frauenheilkunde ·doi:10.1055/s-2007-1026212

CA 125, CA 19-9, CA 15-3 and CEA were measured in 42 patients with histologically verified endometriosis, who had been treated for six months by the LHRH-analogue buserelin (900 mcg/d intranasally). Before therapy, for all of the markers te…

article 1990
Residualendometriose nach LHRH-Analogtherapie
Geburtshilfe und Frauenheilkunde ·doi:10.1055/s-2007-1026452

LHRH analogue therapy has proved effective in the treatment of endometriosis. Although in the majority of patients a marked reduction in AFS implant score is observed, in some cases residual endometriotic foci are macroscopically suspected …

book-chapter 1989
Abhängigkeit zwischen ovarieller Suppression und Rückgang der Endometriose-Implantate bei LHRH-Analog(Buserelin)-Therapie
·doi:10.1007/978-3-642-74784-7_484
article 1989
Abhängigkeit zwischen ovarieller Suppression und Rückgang der Endometriose-Implantate bei LHRH-Analog(Buserelin)-Therapie
·doi:10.1007/bf02417630
book-chapter 1989
Behandlung der Endometriose mit Buserelin: klinische Ergebnisse
·doi:10.1515/9783110869590-006
book-chapter 1989
Behandlung der Endometriose mit Buserelin: metabolische Effekte
·doi:10.1515/9783110869590-011
article 1989
LH-RH agonist (Buserelin): treatment of endometriosis
Archives of gynecology and obstetrics ·doi:10.1007/bf00934075
article 1988
Auswirkungen der Danazol-Therapie bei Endometriose auf Blutbild und Gerinnung
Geburtshilfe und Frauenheilkunde ·doi:10.1055/s-2008-1026554

Over a six-month period, 62 endometriosis patients were given 600 mg per day of the ethisterone derivative danazol. Blood count and coagulation status were checked before and during treatment. There was a significant increase (p less than 0…

book-chapter 1987
Metabolic Effects of Hormonal Treatment for Endometriosis: Danazol versus LHRH-Agonist (Buserelin) Therapy
·doi:10.1159/000414863
article 1987
Metabolische Effekte und allgemeine Nebenwirkungen bei Endometriose-behandlung mit einem LHRH-Agonisten
Geburtshilfe und Frauenheilkunde ·doi:10.1055/s-2008-1035798

Between 1983 and 1986 40 patients were treated for external genital endometriosis with the LHRH agonist buserelin. Ovarian suppression was achieved for a period of six months with a dose of 900 to 1,800 mcg per day. In addition to gynecolog…

article 1987
The effect of naloxone on episodic LH secretion during danazol treatment
·doi:10.1530/acta.0.114s198

Danazol has been extensively utilized in the treatment of endometriosis. The therapeutic effect of this ethisterone derivative is partly attributed to a suppression of gonadotropin secretion. It was the aim of this study to examine whether …

article 1986
Effect of LH-RH agonist therapy in the treatment of endometriosis (German experience).
Progress in clinical and biological research
article 1986
Management of endometriosis.
Progress in clinical and biological research
article 1986
Round table discussion of endometriosis and its treatment.
Progress in clinical and biological research